Ry phenotype. Anti-LAP remedy affects tolerogenic CD103+ CD8 T cells We
Ry phenotype. Anti-LAP treatment impacts tolerogenic CD103+ CD8 T cells We regularly discovered a reduction of CD103+ CD8 T cells in both the spleen and dLNs following anti-LAP therapy (Fig.…